Expression of ZIC family genes in meningiomas and other brain tumors

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Aruga, Jun ^a   Nozaki, Yayoi ^a   Hatayama, Minoru ^a   Odaka, Yuri S ^a   Yokota, Naoki ^b  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN ANTIBODY; PROTEIN ZIC1; PROTEIN ZIC2; PROTEIN ZIC3; PROTEIN ZIC4; PROTEIN ZIC4 ANTIBODY; PROTEIN ZIC5; UNCLASSIFIED DRUG; VIMENTIN; ZINC FINGER PROTEIN; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR; ZIC1 PROTEIN, HUMAN; ZIC2 PROTEIN, HUMAN; ZIC5 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TUMOR; CANCER GRADING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DURA MATER; EPITHELIUM TUMOR; FEMALE; FIBROMA; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MEDULLOBLASTOMA; MENINGIOMA; MOUSE; MULTIGENE FAMILY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN 3T3; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; STEM CELL;

ANIMALS; BRAIN NEOPLASMS; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MENINGIOMA; MICE; NIH 3T3 CELLS; NUCLEAR PROTEINS; STEM CELLS; TRANSCRIPTION FACTORS; VIMENTIN; ZINC FINGERS;

EID: 77950404457     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-79     Document Type: Article

References (16)

1. Perry A, Louis DN, Scheithauser BW, Banerjee R, Margraf L. Meningiomas. World Health Organization Classification of tumours Pathology and genetics of tumours of the nervous system 2007, 164-172. Lyon: IARC Press, Louis DN, Ohgaki H, Wiestler OD, 4.
2. Riemenschneider MJ, Perry A, Reifenberger G. Histological classification and molecular genetics of meningiomas. Lancet Neurol 2006, 5:1045-1054. 10.1016/S1474-4422(06)70625-1, 17110285.
3. Commins DL, Atkinson RD, Burnett ME. Review of meningioma histopathology. Neurosurg Focus 2007, 23:E3. 10.3171/FOC-07/10/E3, 17961040.
4. Inoue T, Ogawa M, Mikoshiba K, Aruga J. Zic deficiency in the cortical marginal zone and meninges results in cortical lamination defects resembling those in type II lissencephaly. J Neurosci 2008, 28:4712-4725. 10.1523/JNEUROSCI.5735-07.2008, 18448648.
5. Aruga J. The role of Zic genes in neural development. Mol Cell Neurosci 2004, 26:205-221. 10.1016/j.mcn.2004.01.004, 15207846.
6. Grinberg I, Millen KJ. The ZIC gene family in development and disease. Clin Genet 2005, 67:290-296. 10.1111/j.1399-0004.2005.00418.x, 15733262.
7. Michiels EM, Oussoren E, Van Groenigen M, Pauws E, Bossuyt PM, Voute PA, Baas F. Genes differentially expressed in medulloblastoma and fetal brain. Physiol Genomics 1999, 1:83-91.
8. Yokota N, Aruga J, Takai S, Yamada K, Hamazaki M, Iwase T, Sugimura H, Mikoshiba K. Predominant expression of human ZIC in cerebellar granule cell lineage and medulloblastoma. Cancer Res 1996, 56:377-383.
9. Pfister S, Schlaeger C, Mendrzyk F, Wittmann A, Benner A, Kulozik A, Scheurlen W, Radlwimmer B, Lichter P. Array-based profiling of reference-independent methylation status (aPRIMES) identifies frequent promoter methylation and consecutive downregulation of ZIC2 in pediatric medulloblastoma. Nucleic Acids Res 2007, 35:e51. 10.1093/nar/gkm094, 1874664, 17344319.
10. Bataller L, Wade DF, Fuller GN, Rosenfeld MR, Dalmau J. Cerebellar degeneration and autoimmunity to zinc-finger proteins of the cerebellum. Neurology 2002, 59:1985-1987.
11. Keller A, Ludwig N, Backes C, Romeike BF, Comtesse N, Henn W, Steudel WI, Mawrin C, Lenhof HP, Meese E. Genome wide expression profiling identifies specific deregulated pathways in meningioma. Int J Cancer 2009, 124:346-351. 10.1002/ijc.23942, 19003955.
12. Inoue T, Ota M, Mikoshiba K, Aruga J. Zic2 and Zic3 synergistically control neurulation and segmentation of paraxial mesoderm in mouse embryo. Dev Biol 2007, 306:669-684. 10.1016/j.ydbio.2007.04.003, 17490632.
13. Aruga J, Inoue T, Hoshino J, Mikoshiba K. Zic2 controls cerebellar development in cooperation with Zic1. J Neurosci 2002, 22:218-225.
14. Vural B, Chen LC, Saip P, Chen YT, Ustuner Z, Gonen M, Simpson AJ, Old LJ, Ozbek U, Gure AO. Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters. Cancer 2005, 103:2575-2583. 10.1002/cncr.21088, 15880380.
15. Sabater L, Bataller L, Suarez-Calvet M, Saiz A, Dalmau J, Graus F. ZIC antibodies in paraneoplastic cerebellar degeneration and small cell lung cancer. J Neuroimmunol 2008, 201-202:163-165. 10.1016/j.jneuroim.2008.01.018, 2582201, 18639938.
16. Graus F, Saiz A, Dalmau J. Antibodies and neuronal autoimmune disorders of the CNS. J Neurol 2009,